Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel H Giles

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Biochimica Et Biophysica Acta|June 5, 2003
Caught up in a Wnt storm: Wnt signaling in cancerRachel H Giles, Johan H van Es, Hans Clevers
Nature Reviews. Nephrology|June 11, 2014
Next-generation sequencing for research and diagnostics in kidney diseaseKirsten Y Renkema, Marijn F Stokman, Rachel H Giles, et al.
Endocrine-Related Cancer|January 29, 2021
Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic reviewSaya Ahmad, Myrthe R Naber, Rachel H Giles, et al.
Cilia|June 4, 2013
The SYSCILIA gold standard (SCGSv1) of known ciliary components and its applications within a systems biology consortiumTeunis Jp van Dam, Gabrielle Wheway, Gisela G Slaats, et al.
Cancer|September 28, 2022
Reply to "von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement"Rachel S van Leeuwaarde, Wendy P G Wolters, Koen M A Dreijerink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancerNiven Mehra, Maarten Penning, Jolanda Maas, et al.
The Lancet. Oncology|April 30, 2022
Patient-reported outcomes: what really matters to patients?Elshad Hasanov, Jaime O Herrera Caceres, Deborah A Maskens, et al.
British Journal of Cancer|June 27, 2020
Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse eventsViktor Grünwald, Martin H Voss, Brian I Rini, et al.
European Journal of Human Genetics : EJHG|October 4, 2007
Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressorMartijn P Lolkema, Dorus A Mans, Laurien H Ulfman, et al.
Research Involvement and Engagement|February 3, 2022
Co-creating with patients an impact framework across the medicine's life cycle: a qualitative study exploring patients' experiences of involvement in and perceptions of impact measuresOleks Gorbenko, Pascale Cavillon, Rachel H Giles, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Biochimica Et Biophysica Acta|June 5, 2003
Caught up in a Wnt storm: Wnt signaling in cancerRachel H Giles, Johan H van Es, Hans Clevers
Nature Reviews. Nephrology|June 11, 2014
Next-generation sequencing for research and diagnostics in kidney diseaseKirsten Y Renkema, Marijn F Stokman, Rachel H Giles, et al.
Endocrine-Related Cancer|January 29, 2021
Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic reviewSaya Ahmad, Myrthe R Naber, Rachel H Giles, et al.
Cilia|June 4, 2013
The SYSCILIA gold standard (SCGSv1) of known ciliary components and its applications within a systems biology consortiumTeunis Jp van Dam, Gabrielle Wheway, Gisela G Slaats, et al.
Cancer|September 28, 2022
Reply to "von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement"Rachel S van Leeuwaarde, Wendy P G Wolters, Koen M A Dreijerink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancerNiven Mehra, Maarten Penning, Jolanda Maas, et al.
The Lancet. Oncology|April 30, 2022
Patient-reported outcomes: what really matters to patients?Elshad Hasanov, Jaime O Herrera Caceres, Deborah A Maskens, et al.
British Journal of Cancer|June 27, 2020
Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse eventsViktor Grünwald, Martin H Voss, Brian I Rini, et al.
European Journal of Human Genetics : EJHG|October 4, 2007
Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressorMartijn P Lolkema, Dorus A Mans, Laurien H Ulfman, et al.
Research Involvement and Engagement|February 3, 2022
Co-creating with patients an impact framework across the medicine's life cycle: a qualitative study exploring patients' experiences of involvement in and perceptions of impact measuresOleks Gorbenko, Pascale Cavillon, Rachel H Giles, et al.
Pageof 13